Health-Related Quality of Life and Coping Strategies in a Cohort Study of Highly Active Antiretroviral Therapy Naïve Patients Adherence

Table 1

Participants’ sociodemographic, behavior, clinical, and laboratory characteristics (n = 109).

Participant variables	Number of participants
	n	(%)
Age
≤35	36	(33.0)
>35	73	(67.0)
Gender
Male	83	(76.1)
Female	26	(23.9)
Skin colour/ethnicity
White	37	(33.9)
Brown	51	(46.8)
Black	21	(19.3)
Marital status
Married/common law marriage	21	(19.3)
Single	88	(80.7)
Schooling (years)
1 to 8	36	(33.0)
9 to 12	36	(33.0)
More than 12	37	(34.0)
Monthly income †
<3 minimum wage	92	(84.4)
≥3 minimum wage	17	(15.6)
Employment status
Employed	93	(85.3)
Unemployed	16	(14.7)
Sexual orientation
Heterosexual	46	(42.2)
Nonheterosexual	63	(57.8)
Alcohol use
Yes	67	(61.5)
No	42	(38.5)
Illicit drug use
Yes	23	(21.1)
No	86	(78.9)
Cigarette smoking
Yes	43	(39.4)
No	66	(60.6)
Mode of transmission
Sexual intercourse	73	(67.0)
Unknown	36	(33.0)
Baseline clinical condition
Asymptomatic	75	(68.8)
Symptomatic	34	(31.2)
Associated STI
Yes	16	(14.7)
No	93	(85.3)
Baseline CD4 cell count (cells/mm^3)
>350	75	(68.8)
≤350	34	(31.2)
Baseline viral load (copies/mL)
<50	13	(11.9)
50–1000	7	(6.4)
>1000	89	(81.7)
Regimens based on DTG/TDF/3TC
Yes	99	(90.8)
No	10	(9.2)

^†Considering the year of 2017, the minimum wage = US$284,00; STI: sexually transmitted infection; DTG: dolutegravir; TDF: tenofovir disoproxil fumarate; 3TC: lamivudine.